The Latest from the Watchlist – Vaccine Stock Flops, Chinese Market Giants, and the Movie Theater Revival
Now I don’t mean to say, “I told you so,” but Varney & Co. didn’t call me the “Man Who Calls It All” for nothing. Just as I predicted a few months back, Pfizer (PFE) stands to lose its COVID-19 vaccine patents and their company’s profitability is about to tank. Hard.
That’s leaves us a wide opening to make some serious profits with its downfall, but that’s not all on my watchlist today.
Early this morning, you should have gotten my watchlist update. Those will be coming in hot every Monday before the opening bell, so make sure to keep your eyes peeled!
If you missed it, don’t worry. You can read all about my favorite stocks for the week here.
Or, just click the video below because I am back with yet another video to take an even deeper dive into these stocks. PFE may be on its way out, but two other heavy-hitting Chinese stocks, NIO and BABA, are going to take off before the year is out.
Until next time,
Shah Gilani
The patent on Phizer’s vaccines is important because the drugs that they have in their pipeline use the same platform. If the patent information is shared, it will put all of their future drug candidates at risk.
I put a big bet on Canopy Growth Corp and it has gone from $30 down to $22. I feel I should hold on till Cannibis becomes legal, what do you think??
i put a big bet on SKLZ @ $35 & NOW its at $13.39 & change. what to do